Director, Patient Recruitment & Retention Strategy

Exelixis; Alameda (CA); On-site; USD 164,500 - 234,500; Full time

Benefits offered by this job

401k plan

Medical

Dental & Vision

Life & Disability

Flexible Spending Accounts

Annual bonus

Stock options

Vacation days

Holidays

Sick days

Job summary

Exelixis seeks a leader to drive the global informed consent program, ensuring alignment with regulatory standards and trial requirements. You will manage cross-functional governance with internal teams, CROs, vendors, and sites to meet enrollment and retention goals.

You will update templates to reflect latest guidance, maintain ICH/GCP compliance, and support inspection activities while partnering with study delivery leaders to keep trials on schedule.

Qualifications

• Minimum 13 years of related experience with BS/BA or 11 years with MS/MA.
• Experience across tumor indications and clinical trial phases.
• Experience in electronic data management.
• Experience reducing patient and site burden during clinical trials.
• Experience partnering with sites is a plus.

Responsibilities

• Lead cross-functional governance and informed consent programs across trials.
• Ensure ICH/GCP compliance in all consent processes and forms.
• Collaborate with CROs to align processes and templates with Exelixis standards.
• Develop tactics to recruit and retain participants and engage under-represented populations.
• Assist in health authority inspections and corporate initiatives as needed.

Skills

Leadership

GCP knowledge

Regulatory knowledge

Stakeholder management

Analytical thinking

Communication

Education

BS/BA in Science/Business

MS/MA in Science/Business

Equivalent education & experience

Certification in assigned area

Job description

Exelixis seeks a leader to drive the global informed consent program, ensuring alignment with regulatory standards and trial requirements. You will manage cross-functional governance with internal teams, CROs, vendors, and sites to meet enrollment and retention goals.

You will update templates to reflect latest guidance, maintain ICH/GCP compliance, and support inspection activities while partnering with study delivery leaders to keep trials on schedule.